Tenofovir for children and adults with chronic hepatitis B

Huijuan Li, Minyan Yang, Mina Ma, Zijun Li, Meixuan Li, Long Dong Zhu, Liang Yao, Junfeng Li, Linda Zhong, Kehu Yang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.

Original languageEnglish
Article numberCD015586
JournalCochrane Database of Systematic Reviews
Volume2023
Issue number9
DOIs
Publication statusPublished - Sept 8 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ASJC Scopus Subject Areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Tenofovir for children and adults with chronic hepatitis B'. Together they form a unique fingerprint.

Cite this